Anti-CD62L antibody [EPR30513-525]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal CD62L antibody. Suitable for IHC-P, WB and reacts with Transfected cell line - Human, Human samples.
View Alternative Names
CD62L, LNHR, LYAM1, SELL, L-selectin, CD62 antigen-like family member L, Leukocyte adhesion molecule 1, Leukocyte surface antigen Leu-8, Leukocyte-endothelial cell adhesion molecule 1, Lymph node homing receptor, TQ1, gp90-MEL, LAM-1, LECAM1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD62L antibody [EPR30513-525] (AB324590)
Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labeling CD62L with ab324590 at 1/100 (4.88 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining on human tonsil.
The primary antibody was incubated for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD62L antibody [EPR30513-525] (AB324590)
Immunohistochemical analysis of paraffin-embedded Human Non-Hodgkins Lymphoma tissue labeling CD62L with ab324590 at 1/100 (4.88 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining on human Non-Hodgkins Lymphoma.
The primary antibody was incubated for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD62L antibody [EPR30513-525] (AB324590)
Immunohistochemical analysis of paraffin-embedded (A) HEK-293T (human embryonic kidney epithelial cell) transfected with a human CD62L (L-selectin) expression vector containing a his tag. (B) HEK-293T cells transfected with a human CD62E (E-selectin) expression vector containing a his tag. (C) HEK-293T cells transfected with a human CD62P (P-selectin) expression vector containing a his tag. (D) HEK-293T cells transfected with empty vector containing a his tag. tissue labeling CD62L with ab324590 at 1/2000 (0.244 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining on (A) HEK-293T cells transfected with a human CD62L (L-selectin) expression vector containing a his tag, no staining on (B) HEK-293T cells transfected with a human CD62E (E-selectin) expression vector containing a his tag, (C) HEK-293T cells transfected with a human CD62P (P-selectin) expression vector containing a his tag and (D) HEK-293T cells transfected with empty vector containing a his tag.
The primary antibody was incubated for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD62L antibody [EPR30513-525] (AB324590)
Immunohistochemical analysis of paraffin-embedded (A) Jurkat (human T cell leukemia T lymphocyte from peripheral blood) cell pellet, (B) HeLa (human cervical adenocarcinoma epithelial cell) cell pellet tissue labeling CD62L with ab324590 at 1/2000 (0.244 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining on (A) Jurkat cell pellet, no staining on (B) HeLa cell pellet.
The primary antibody was incubated for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- WB
Supplier Data
Western blot - Anti-CD62L antibody [EPR30513-525] (AB324590)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
CD62L is a glycoprotein of approximately 80-100 kDa and is detected as a 40 kDa band after treatment with the deglycosylation enzyme Peptide : N-glycosidase F (PNGase F).
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-CD62L antibody [EPR30513-525] (ab324590) at 1/1000 dilution
Lane 1:
Untreated Jurkat whole cell lysate at 20 µg
Lane 2:
Jurkat lysate treated with Protein Deglycosylation Peptide:N-glycosidase F (PNGase F) at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 40 kDa,80 kDa,36 kDa
false
Exposure time: 26s
- WB
Supplier Data
Western blot - Anti-CD62L antibody [EPR30513-525] (AB324590)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Negative control : HeLa, human liver
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-CD62L antibody [EPR30513-525] (ab324590) at 1/1000 dilution
Lane 1:
Jurkat (human T cell leukemia T lymphocyte from peripheral blood) whole cell lysate at 20 µg
Lane 2:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
Human tonsil tissue lysate at 20 µg
Lane 4:
Human liver tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 80 kDa,36 kDa
false
Exposure time: 26s
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD62L antibody [EPR30513-525] (AB324590)
Immunohistochemical analysis of paraffin-embedded Human liver tissue labeling CD62L with ab324590 at 1/100 (4.88 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Negative control : No staining on human liver.
The primary antibody was incubated for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com